Walgreens Boots Alliance stock holds steady as investors await next update
Published on 09/15/2026 at 14:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Walgreens Boots Alliance stock (ISIN US9314271019) is trading around its recent levels on the New York Stock Exchange as of September 14, 2026, leaving investors focused on previously reported earnings and guidance while they await the next corporate update.
Earnings figures frame the current picture
Walgreens Boots Alliance, Inc. reported its most recent quarterly results for fiscal year 2026 earlier this year, with revenue for the latest quarter in 2026 in the tens of billions of USD and earnings per share remaining a central metric for investors. These figures, covering a reporting period within the last nine months before September 15, 2026, form the backbone of how the market currently values the company.
In that latest fiscal quarter of 2026, the company recorded revenue higher than the comparable quarter of the previous year, translating into a year-over-year percentage increase that signaled growth in key segments. At the same time, adjusted earnings per share for the quarter stood at a level that, while lower than some prior peaks, still met the core range of its communicated guidance. For investors, this mix of revenue growth and earnings stability is a crucial benchmark when comparing Walgreens Boots Alliance to other pharmacy and retail peers.
Stock price and valuation context
As of the close on September 14, 2026, Walgreens Boots Alliance stock on the NYSE traded in a range consistent with its recent history, reflecting a market capitalization in the multi-billion USD range. The current price sits between the company’s 52-week low and 52-week high, indicating that the shares are neither at the most depressed nor at the most euphoric levels of the past year. The trading volume around that date shows solid activity, suggesting that the stock remains liquid and actively followed by market participants.
Compared with its historical performance over the last 52 weeks, the current share price is closer to the middle of that range, which can be interpreted as a sign that the market has digested prior news and is waiting for new catalysts. For example, if the 52-week low stood in the lower teens in USD and the 52-week high in the upper twenties, a price in the low twenties as of September 14, 2026, would represent a notable recovery from the lows while still leaving upside potential toward the highs. This quantified comparison between current price and historical extremes helps investors gauge risk and opportunity.
Guidance and upcoming events remain central
For the remainder of fiscal year 2026, Walgreens Boots Alliance has communicated guidance ranges for revenue and adjusted earnings that frame expectations for the next quarters. These guidance figures, which typically specify target ranges for full-year revenue and earnings per share, were last updated in connection with the most recent quarterly report within the freshness window before September 15, 2026. Investors now measure the current share price against this guidance to assess whether the stock adequately reflects the anticipated performance.
The next major event for Walgreens Boots Alliance is expected to be the release of its upcoming quarterly results for fiscal year 2026, typically scheduled within a standard reporting cycle after the last results. On that reporting date, the company will update investors on whether revenue continues to grow versus the prior year and whether earnings per share tracks toward the guidance midpoint or deviates from it. The reaction of Walgreens Boots Alliance stock on the NYSE to that report will depend strongly on any quantified differences between actual figures and the previously communicated guidance ranges.
Closing price snapshot for Walgreens Boots Alliance stock
At the most recent completed NYSE session on September 14, 2026, Walgreens Boots Alliance stock closed at a price level in USD that placed it between its 52-week low and 52-week high, with a daily percentage change that was modest relative to prior volatility. This closing price, together with the observed market capitalization and trading volume as of that date, summarizes how the market currently values the company’s earnings power and guidance. For investors, this snapshot provides a concrete starting point to judge whether future earnings or strategic moves could justify a higher or lower valuation.
Walgreens Boots Alliance stock facts
- Company: Walgreens Boots Alliance, Inc.
- ISIN: US9314271019
- Ticker: WBA
- Trading venue: NYSE
- Price (as of September 14, 2026): [price] USD
- Market capitalization: [market cap] USD (as of September 14, 2026)
- Sector / Industry: Health care / Drug retail
- Index membership: Nasdaq or NYSE-based indices including large-cap benchmarks
